Neuroscience News

With limited therapeutic options available, Wu Tsai Neuro affiliate Michelle Monje and team have turned to studying the growth patterns of brain tumors that occur in glial cells to identify new treatment avenues.

A new study co-authored by Knight Initiative Director Tony Wyss-Coray demonstrates a simple way of studying organ aging by analyzing distinct proteins in blood, enabling the prediction of individuals’ risk for diseases.

Wu Tsai Neuro affiliates Karl Deisseroth, Carolyn Rodriguez, Vivek Buch, Paul Nuyujukian, and team have created a super-charged, multidisciplinary in-patient research program and laboratory to better understand neuropsychiatric disorders.

A new technique using deep brain stimulation tailored to each patient exceeded researchers’ expectations in treating the cognitive impairments from moderate to severe traumatic brain injury.

It may not be smart, but we value something more if we’ve put a lot of sweat equity into it. Affiliates Neir Eshel and Rob Malenka, with support from the Wu Tsai Neuro–funded NeuroChoice Initiative, may have figured out the biochemical basis of why.

Wu Tsai Neuro affiliate Michelle Monje and other researchers find understanding the interplay between cancer tumors and the nervous system may be essential for winning the war on cancer.

Stanford Medicine queried Wu Tsai Neuro and Knight Initiative affiliates share their expertise on the what the human brain are thinking about humans vs AI.

Wu Tsai Neuro affiliate Josef Parvizi unveils the surprising role of a small structure sandwiched between the brain’s two hemispheres.

When Anqi Zhang arrived at Stanford University as a postdoc, she had just spent six years learning to design and build brain implants: miniscule devices that could record the activity of neurons while causing minimal tissue damage.

Pathologist Siddhartha Jaiswal discovers a surprising twist to our biology: age-related mutations that increase the risk of blood disease also protect against brain disease.

A study in mice finds that white matter — the tissue that transmits messages around the brain — shows the greatest changes as the animals age.

The new tool, pioneered by Anqi Zhang, now a Stanford postdoc with Karl Deisseroth and Zhenan Bao, could make it possible to study and treat the brain without causing tissue damage.

Researchers with Stanford’s Wu Tsai Neurosciences Institute aim to improve gut motility and health outcomes for preterm babies through foundational research on the nervous system of the gut, called the enteric nervous system (ENS).

Tiny DNA circles harbor cancer-associated oncogenes and immunomodulatory genes that promote cancer development.

Bioluminescence helps Wu Tsai Neuro affiliate Michael Lin and team develop cancer drugs for brain.

Wu Tsai Neuro affiliates and others are accepted into competitive cohort in Stanford Medicine's new Catalyst program.